See real-world impact sooner with detailed, real-time data

Support R&D, safety surveillance, and label expansion with representative, complete and timely device data that exceeds FDA standards for data quality, data provenance, and audit readiness.

Reach out and we’ll schedule a meeting

Access complete, research-ready data for every step of the device lifecycle

From pre-market development through post-market surveillance, Truveta provides the most complete real-world data available — enabling your teams to evaluate device performance, improve outcomes, and accelerate innovation.

EHR data from more than 120 million patients, including clinical notes and images, linked with closed claims from more than 200 million patients.

Read how real-world data is replacing trials and registries

Read the whitepaper
120M+

patients

200M+

patients linked with closed claims

45M+

unique devices

5+

years longitudinal patient data

7B+

clinical notes

100M+

imaging studies

Data are de-identified, updated daily, and audit-ready

Read how real-world data is replacing trials and registries

Read the whitepaper

Regulatory-grade safety and effectiveness data

Truveta enables medical device companies to generate FDA-aligned, real-world evidence faster and more efficiently than ever before. With linked EHR, closed claims, and longitudinal outcomes, Truveta provides a robust alternative to traditional post-market registries and costly RCTs.

What you can do with Truveta

Confidently compare devices across diverse, representative populations in weeks, not years

Leverage provenance-backed data to trace evidence to source for regulatory submissions

Monitor safety signals in real time, across care settings

Generate evidence to support label expansion and payer reimbursement

Analyze UDI-level data to study outcomes such as:

  • In-hospital mortality
  • 30-day readmissions
  • Major adverse events
  • Length of stay

“We saved years and millions of dollars by using Truveta Data instead of running a traditional RCT.”

Michael R, Jaff, DO

Chief Medical Officer and Vice President, Medical Affairs, Innovation and Technology, Peripheral Interventions, Boston Scientific
Case study
Blog post highlighting findings from the REAL-PE study's exploration of novel pulmonary embolism treatments using real-world data from electronic health records (EHRs). The emphasis is on the comparative safety analysis conducted by independent researchers, providing insights into major bleeding events associated with novel pulmonary embolism interventions.

Boston Scientific used Truveta to compare the EKOS™ Endovascular System to Inari’s FlowTriever, revealing a higher bleeding risk with the competitor. The study was published and presented within 5 months, saved years and millions that it would have taken to complete a RCT, and improved adoption of the EKOS(TM) Endovascular System.

Read the case study
Blog post highlighting findings from the REAL-PE study's exploration of novel pulmonary embolism treatments using real-world data from electronic health records (EHRs). The emphasis is on the comparative safety analysis conducted by independent researchers, providing insights into major bleeding events associated with novel pulmonary embolism interventions.

Real-world data to support your next indication - faster than you thought possible

Expand access to your therapy by showing value in the real world. With Truveta, you can analyze diverse patient populations and care settings to demonstrate broader effectiveness and cost savings.

Build your case for:
  • Payer reimbursement
  • Indication expansion
  • Off-label usage validation
Truveta Data in action

A cardiovascular device manufacturer used Truveta Data to demonstrate improved long-term outcomes in high-risk patients – accelerating payer engagement and supporting label expansion efforts. With commercial, Medicare, and Medicaid claims linked to EHR data, real-time visibility into off-label use, and comprehensive longitudinal records, Truveta offers the real-world evidence needed to expand access and validate broader indications.

See how RWD supports label expansion

Clinical notes reveal what structured data misses

Truveta captures 7B+ clinical notes – including progress notes, operative reports, discharge summaries, and more – offering insight into treatment rationale, complications, and adverse events.

Imaging data paired with EHR and claims

Leverage 100M+ medical images (CT, MRI, X-ray, and more) to:

  • Assess device performance and anatomical change over time
  • Support multimodal AI model development
  • Analyze recovery trajectories and safety indicators

Device innovation across specialties

Truveta supports medical device research across a broad range of specialties, including cardiovascular, neurology, surgical, diagnostics, and remote monitoring.

Use Truveta Data to:

Compare bleeding risks and long-term outcomes in embolism treatments

Analyze treatment patterns and safety signals for neurostimulators

Evaluate implant performance and surgical outcomes with integrated imaging and clinical notes

Connect remote monitoring device data with EHR outcomes for predictive modeling

No matter your device category, Truveta’s real-world evidence helps you move faster, prove value, and improve care.

Advance your research with Truveta

Whether you’re validating a new indication, evaluating safety signals, or preparing for regulatory submission – Truveta offers the scale, speed, and scientific rigor your team needs to succeed.

Contact us today for a demo and see how Truveta’s data can power your medical device research.